Please Wait

Applying Filters...

Terconazole
CEP/COS
Table View

Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Terconazole

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 1 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 10 FDA Orange Book, 1 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

1 Jai Radhe Sales, 3 Nanjing Well Pharmaceutical, 2 Actylis, 8 BASF, 1 Finar, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 7 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers, 12 Topical, 6 Emulsifying Agents, 6 Parenteral, 5 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 4 Surfactant & Foaming Agents, 2 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Lubricants & Glidants, 1 Granulation, 1 Co-Processed Excipients

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

1 DATA COMPILATION #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Finished Drug Prices

MARKET PLACE

6 APIs

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/10/2024	Johnson & Johnson Innovative Medicine	U.S.A	JANSSEN PHARMACEUTICA NV Beerse BE	R0-CEP 2000-219 - Rev 02	Terconazole	2004-11-16	Withdrawn by Holder	Chemical	2006-07-31	1270

Contact us
to update this info

Terconazole

Terconazole

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

6 USDMF

1 CEP/COS

1 EU WC

3 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers

10 FDA Orange Book

1 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;VAGINAL - 0.4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUPPOSITORY;VAGINAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;VAGINAL - 0.8%

RELATED EXCIPIENT COMPANIES

1 Jai Radhe Sales

3 Nanjing Well Pharmaceutical

2 Actylis

8 BASF

1 Finar

4 Gangwal Chemicals

1 Nanjing Bold Chemical

7 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Solubilizers

12 Topical

6 Emulsifying Agents

6 Parenteral

5 Thickeners and Stabilizers

4 Film Formers & Plasticizers

4 Surfactant & Foaming Agents

2 Direct Compression

1 Rheology Modifiers

1 API Stability Enhancers

1 Lubricants & Glidants

1 Granulation

1 Co-Processed Excipients

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 Finished Drug Prices

MARKET PLACE

6 APIs

REF. STANDARDS & IMPURITIES

2 EDQM

1 USP

3 Others

Filters

CREAM;VAGINAL - 0.4% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUPPOSITORY;VAGINAL - 80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;VAGINAL - 0.8% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons